CLINICAL_TRIALS
trial_result
· 2019-02-12
Clinical Trial Update: Prevention of Delirium in Inpatients Utilizing Melatonin [Phase 3]
Summary
A Phase 3 clinical trial assessing melatonin for prevention of delirium in inpatients was terminated; results were posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Delirium | Phase 3 | Status: TERMINATED | Results posted: 2019-02-12